2 Stem Cells to Clinical Trials Dr. Wise Young, Presenter Santina Muha, Moderator
3 The Central Jersey Spinal Cord Association Dr. Wise Young The W.M. Keck Center for Collaborative Neuroscience The Spinal Cord Injury Project Patricia Morton & Jim Bennet Santina Muha
4 Thisabled is asking participants to assist one of our partners by filling out a survey on SCI at: om/aytsreg.aspx?aid=217. $10.00 will go to the Central Jersey Spinal Cord Association for every survey which is completed.
5 The Present Situation We collect stem cells from blood, bone marrow, aborted fetuses, fertilized eggs, and other sources. Cell transplants are either autografts (from a person to self) or matched (HLA) with recipients. Only blood and bone marrow cells are available in sufficient diversity for matching HLA We don t have reliable methods of growing large quantities of cells from blood or bone marrow. Stem cells are still classified by developmental stage and source, rather than what they are and do.
6 Current Business Models Blood banks collect voluntarily donated blood. They test, store, match, and ship blood cells. In vitro fertilization clinics are repositories of fertilized eggs and blastocysts from parents. Private cord blood banks store umbilical cord blood cells for babies who might need them in the future. Public cord blood banks store umbilical cord blood to provide HLA-matched cells for patients. Bone marrow registries provide a database to match walking donors with potential recipients.
7 Future Business Models Universal stem cells. Create a population of immune-tolerized babies by in utero vaccination to a optimized universal stem cell line. Universal stem cell library. Develop cell lines that can match HLA antigens of 90% of a given population. Personalized stem cell service. Provide some cell samples and come back several weeks later for a unit of your own stem cells.
8 Stem Cell Definition Old Definition: Undifferentiated pluripotent cells (able to produce many kinds of cells). Stem cells: Pluripotent cells that can replicate themselves. Progenitor cells. Multipotent cells that do not replicate themselves. Precursor cells. Cells that differentiate into or make a few other related cells but not themselves. Emerging concept that stem cells are the only cells that can replicate themselves.
10 Dedifferentiation Differentiation has long been believed to be a oneway street. The dogma is that once cells have differentiated, they cannot dedifferentiate. Scientists have long known that dediffentiation can occur. For example, Dolly the sheep was cloned by dedifferentiation of a breast cell nucleus. Dedifferentiation suggests a process by which a differentiated cell can revert to an earlier stage, all the way back to stem cells or even an egg.
11 Transdifferentiation Transdifferentiation is the process where one type of cell makes cells of another type, i.e. a bone marrow cell makes neurons. Many scientists consider transdifferentiation to be impossible, e.g. once a cell has differentiated into mesenchymal, it cannot make neural cells. Transdifferentiation would imply that a differentiated cell can produce differentiated cells of another type without first dedifferentiating to a stem cell.
13 Embryonic Stem Cells Embryonic stem cells are pluripotent cells derived from the inner cell mass of blastocysts,. They are not embryonic. A blastocyst becomes an embryo after it develops a midline (primitive streak) and implants in the uterus. They can also be made from germ cells, by fusing with somatic cells, or by genetic induction. Embryonic stem cells can produce all cells of the body except for the placenta and amnion.
14 Stem Cell Mythology Myth 1. Embryonic stem cells are easy to grow. They are difficult and very laborious to grow, requiring a full-time technician to maintain a line. Myth 2. Embryonic stem cell lines are similar. Every stem cell line turns out to be very different both in growth requirements and pluripotency. Myth 3. Embryonic stem cells produce all cells. They readily produce neural and mesenchymal stem cells in vitro but less readily to others.
15 Neural Stem Cells Neural stem cells (NSC) are the first cells that embryonic stem cells produce in development. They are the default cell type. NSC make cells of the brain, including neurons, astrocytes, oligodendroglia, and microglia. They are present in brain, in the subventricular zone. Neural progenitors are the easiest of all stem cells to grow. They don t need serum or feeder cells. All they need is FGF and culture medium.
17 Mesenchymal Stem Cells Mesenchymal stem cells (MSC) are mesodermal in origin and form blood, bone, and muscle. MSC s are present in bone marrow and form all the blood cells, myoblasts, and osteoblasts. They can be stimulated by hormones and drugs to proliferate (GM-CSF, lithium). MSC s can be isolated and grown in culture from bone marrow, cord blood, and umbilical cord (Wharton s jelly).
18 Endodermal Stem Cells Endodermal cells form the yolk sac and give rise to the epithelium of the alimentary and respiratory tracts, as well as parenchyma of associated glands. They interact with mesodermal stem cells to form many of the internal organs (pancreas, liver, gut, gall bladder, adrenal glands, and mesenteric plexus). Our intestines have large numbers of stem cells. These include cells called enteric glia that make neurons and can myelinate axons.
19 Stem Cell Gene Therapy Most people think of stem cells only from the viewpoint of cell replacement therapies. Stem cells are well suited for gene delivery for the following reasons: Transplants allow local delivery of gene products The genetic manipulation can be done ex-vivo. Delivery is sustained because the cells renew. The cells can be programmed suicide when done. No gene therapy has yet been approved because viruses are not trusted as a delivery vehicle.
20 Stem Cell Nitches Stem cells are the most regulated cells of the body and for good reason. One cannot have pluripotent cells wandering our body. In adults, stem cells must fit into a nitch that tell them how much and what cells to produce. This is the only way they can make more cells. The cells must express appropriate antigens for immune rejection in order to prevent cancer development after transplantation.
21 Cancer Stem Cells Cancer stem cells. Only stem and cancer cells reproduce themselves, giving rise to the concept of cancer stem cells. Tumors have cell-nitches that tell stem cells to produce tumor cells. If so, this explains why most chemotherapies destroy stem cells. A therapeutic target for cancer. We can treat solid tumors by disrupting communications between tumor nitches and stem cells.
22 Endogenous Stem Cells Endogenous stem cells. There are substantial numbers of pluripotent stem cells present in adults. Why not stimulate endogenous stem cells instead of transplanting additional cells? Can endogenous stem cells be stimulated to proliferate and produce more stem cells? Several drugs are already known to do so: GM-CSF is known to stimulate bone marrow. Lithium stimulates many types of stem cells. Stress and inflammatory interleukins also do so.
23 Immune Compatibility Autografts. One s own cells are obviously the most immune-compatible cells. However, autografts may not be desirable for treatment of genetic diseases. Popular HLA antigens. Identify cells with the most popular HLA antigens to create a library of cell lines that matches 80-90% of a population. Induced pluripotent stem cells. Recent studies indicate that one can make pluripotent stem cells by transfecting as few as four genes into skin cells.
24 Induced Pluripotent Cells Inducting pluripotent stem cells. (1) culture differentiated somatic cells, (2) transfect with Oct3/4, Sox2, Klf4, and c-myc, (3) grow cells on mitotically inactivated feeder cells, (4) the cells go on to make pluripotent stem cells.
25 A Paradigm Shift? Thomas Kuhn described science as periods of relative stability punctuated by revolutions that he calls paradigm shifts. We are in the midst of a biological paradigm shift that is as or more profound than transition from Newtonian physics to Einsteinein relativity. Stem cells have not only overturned every major assumption that we have in cell biology and some dogmas that we did not even realize were dogmas.
26 Dogmas Overturned We were born with neurons that we die with. New neurons are being born throughout adult life. Cells do not dedifferentiate or transdifferentiate. A somatic nucleus can de-differentiate to an egg. Bone marrow and neural stem cells are multipotent. Cells are independent entities. Stem cells tend to fuse with other cells. Cells usually replicate themselves. Only stem cells routinely replicate themselves. Self-replication is the exception rather than the rule.
27 The Future of Stem Cells Future stem cell therapeutics will be different from the current approach of harvesting, storing, and matching cells for transplantation. No stem cell source today can meet clinical demand, if any stem cell therapy is shown to be effective for any major disease or condition. It would be a moral catastrophe. What do we do when we discover the cure for Alzheimer s disease but do not have enough cells to cure 1% of people?
28 Conclusions The Present Harvest, bank, and transplant. Limited sources of pluripotent cells. Embryonic stem cell, difficult regulatory hurdles, political interference, embryonic vs. adult stem cells, and the ethics of endless debate. The Future Producing and cloning cells. Immune compatibility, tolerance, and privilege. Reducing tumor risk. Differentiation and progenitors. Paradigm shifts and overturned dogmas. Clinical trials.
29 Therapeutic Targets Wise Young, Ph.D., M.D. W. M. Keck Center for Collaborative Neuroscience Rutgers University, Piscataway, NJ
32 Barriers to Regeneration Injury site. The injury site is bereft of cell adhesion molecules and surrounded by reactive gliosis. Time. Axons grow no faster than hair, less than a mm per day. Distance. The distance of axonal growth may exceed a meter. Growth inhibitors. Several factors stop axon growth, i.e. Nogo, chondroitin-6-sulfate proteoglycan.
33 Regenerative Therapies Bridging the injury site. The injury site is often bereft of cell adhesion molecules and surrounded by reactive gliosis. Cells can form a bridge. Sustained growth support. Axonal growth takes many months and sustained growth factor support is required. Neurotrophins stimulate axon growth. Blocking growth inhibitors. Myelin express axonal growth inhibitor Nogo, which can be blocked by Nogo antibodies or rhok/rho blockers.
34 Cellular Bridges Cell transplants will form a living bridge across the injury site, supporting axonal growth across otherwise inhospitable terrain. The bridge does not have to be permanent. After the axons have grown past, the bridge can quietly disappear after several months. Cells injected into surrounding spinal cord will migrate into the injury site. Cells injected into the injury site form an isolated island at the injury site.
35 Growth Factors Neurotrophins stimulate axonal growth nerve growth factor (NGF) brain-derived neurotrophic factor (BDNF) neurotrophin-3 (NT-3) glia-derived neurotrophic factor (GDNF) The injured spinal cord produces cytokines and neurotrophins after contusion injury. The cytokines attract inflammatory cells and stem cells to the injury site. Other factors such as MIF act on CD44 to keep stem cells from migrating away.
36 Growth Inhibitors Several factors in spinal cord inhibits axon growth Nogo. Located in myelin, this protein activates the nogo receptor on axons and stops growth. Chondroitin-6-sulfate-proteoglycan (CSPG). This extracellular protein stops axonal growth. Ephrins. These guide axon growth into dorsal or ventral cord. These factors explain why central nervous system does not regenerate while the peripheral nerves can. Blockade of these factors will allow regeneration.
37 Combination Therapy Bridge injury site with immune compatible cells: HLA-matched cord blood mononuclear cells Bone marrow mesenchymal stem cells Provide or stimulate growth factors Lithium stimulates neurotrophin production Intrathecal application of neurotrophins Block axon growth inhibitors (nogo, CSPG) Nogo receptor protein/blocker Chondroitinase
38 Lithium and Cord Blood Mononuclear Cell Therapy of Spinal Cord Injury Wise Young, PhD MD W. M. Keck Center for Collaborative Neuroscience Rutgers University, Piscataway, NJ
39 Umbilical Cord Blood (UCB)
40 UCB-treated Conditions Duchenne s muscular dystrophy (Kong, et al. 2004, Zhang, et al., 2005). Infantile Krabbe s disease (Escolar, et al., 2005) Cerebral palsy (Kurtzberg, et al., personal) Stroke (Lin, et al., personal). Autoimmune diseases. Multiple sclerosis, Devic s disease Systemic lupus erythematosus Diabetes mellitus
41 Neonatal Rat Blood Culture 25.0 Growth Curves - RNBC Plasma layer Buffy coat layer DMEM 10% FCS bfgf EGF 12.5 Clonal isolation N01.1 Transplant Erythrocytes, neutrophils 50 ml conical vial after centrifugation 5 mm Weeks after Plating N01 - WT G02 - GFP
42 Neonatal Rat Blood N01.1 cells N01 cells were isolated from rat neonatal blood cells of Sprague-Dawley (SD) pups and cultured in growth media with DMEM, 10%FBS, EGF and bfgf. At 6 weeks, 60% of N01 cells are nestin-positive. A clonal line was isolated and named N01.1. All cells in the clone expressed nestin (A, green). N01.1 cells can be cultured for long period of time without showing changes in morphology or nestin expression. When serum was withdrawn from the growth media, N01.1 cells formed spherical structure (B & C), similar to neurospheres formed by neural stem cells (data presented by Dongming Sun at the First Scientific Annual Meeting, Stem Cell Research in NJ)
43 N01.1 Transplantation 1 week after transplantation into uninjured spinal cords
44 Lithium (Li) Lithium strongly stimulates proliferation of many types of stem cells, including umbilical cord blood mononuclear (UCBM) cells. We recently discovered that lithium increases production and secretion of neurotrophins by UCBM cells both in vitro and in vivo. Lithium has long been used to treat manic depression and stimulatory effects of lithium on neural stem cells may be responsible for its effects.
45 Lithium and Regeneration Yick LW, So KF, Cheung PT, Wu WT (2004). Lithium chloride reinforces the regenerationpromoting effect of chondroitinase ABC on rubrospinal neurons after spinal cord injury. J. Neurotrauma 21: Su H, Chu TH, Wu W (2007). Lithium enhances proliferation and neuronal differention of neural progenitor cells in vitro and after transplantation into the adult rat spinal cord. Exp. Neurol Dill J, Wang H, Zhou F, Li S (2008). Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS. J. Neurosci. 28:
46 Lithium and Degeneration Yeh HL, Tsai SJ (2008). Lithium may be useful in the prevention of Alzheimer s disease in individuals with presenile familial Alzheimer s disease. Medical Hypotheses. DeSarno P, Axtell RC, Raman C, Roth KA, Alessi DR, Jope RS (2008). Lithium prevents and ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 181: Feng HL, Leng Y, Ma CH, Ren M, Chuang DM (2008). Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience 155:
47 Lithium & ALS Fornai, et al. (2008). Lithium delays progression of amyotrophic lateral sclerosis. Proc. Nat. Acad. Sci. 105: Daily doses of lithium (plasma level ). 44 patients with ALS randomized to riluzole (control) or riluzole plus lithium. At the end of 15 months, 29% of control group died but none in the riluzole+lithium group. Lithium group showed no significant motor deterioration whereas control group deteriorated.
48 Lithium and Stem Cells Lithium has been used for over 100 years to treat manic depression. It was one of the first drugs to be approved by the Food and Drug Administration. Therapeutic serum levels of mm stimulate proliferation of bone marrow, neural, and other stem cells in vitro and in vivo. Lithium-treated patients with manic depression have more gray matter and higher neuronal density in their brains.
49 Lithium Mechanisms
50 Recent Lithium Studies Lithium stimulates proliferation of neural and other stem cells but it stimulates neurotrophin production only in umbilical cord blood cells. Other glycogen synthetase kinase beta-3 (GSK-b3) inhibitors have similar effects as lithium. Calcineurin inhibitors (cyclosporin and FK506) block lithium, suggesting that GSK-3ß acts via NFAT (nuclear factor of activated t-cells).
52 Lithium Stimulates Proliferation N01.1 cells were cultured in 3 mm lithium chloride for 7 days. Lithium treated cultures had 359% more cells than control cultures grown without lithium.
53 OEG Survival at 2-15 weeks Green fluorescent protein (GFP) expressing OEG cells in whole-mounted rat spinal cord at 2 weeks (2w) or 14 weeks (14w) after a 25-mm contusion and treatment with methylprednisolone (MP) or/and cyclosporine A (CyA).
54 Lithium Effects on N01.1 Lithium-treated Saline-treated Spinal cord at 2 weeks
55 Lithium Effect on GFP in Vivo GFP mrna measured by real-time RT/PCT in un-injured rat spinal cord at 2 weeks after NO1.1 cell transplantation. GFP mrna was detectable but very low in salinetreated rats. Lithium-treated rats had 1000x more GFP mrna than in saline-treated rats.
56 Lithium & Growth Factors Real-time PCR showed that LIF, GDNF, NT3, NGFa, and NGFb mrna levels were 3-5 times higher in spinal cords of N01.1-transplanted and lithium-treated rats than in N01.1-transplanted (n=6) and saline-treated rat (n=6).
57 Rationale for Trials Cord blood cells have many advantages Long history of cord blood safety in human use. GMP source of HLA-matched cells for transplantation Preclinical shows cord blood mononuclear cells are well behaved after transplantation to rat spinal cords. Methyprednisolone and Lithium A single bolus dose of methylprednisolone (MP) markedly (4x) improves survival of transplanted cells Lithium stimulates proliferation and neurotrophin production by cord blood mononuclear cells. Combination UCBMC, MP, and lithium.
58 China Spinal Cord Injury Network (ChinaSCINet) Wise Young, Ph.D., M.D. W. M. Keck Center for Collaborative Neuroscience Rutgers University, Piscatway, NJ
59 Genesis of ChinaSCINet In 1997, a 17-year old gymnast (Sang Lan) broke her neck at the Good Will Games in New York. When she was returning to China, she cried and asked how the cure for SCI would come to China. I told her that clinical trials in China is the only way to bring therapies to China. I promised her I would do my best to bring trials to China. In 2003, I met the mother of a young man with SCI (Suzanne Poon) and asked her to help raise funds for the China Spinal Cord Injury Network (ChinaSCINet).
60 Spinal Cord Injury in China Spinal cord injury (SCI) incidence in China increased tenfold (from 6.5 to 65 cases/million) from 1995 to 2005, i.e. >85,000 new cases/year. Prevalence of chronic SCI >800,000 in 2008 and is likely to exceed a million by 2010 in China. ChinaSCINet has 25 leading SCI centers in mainland China, Hong Kong, and Taiwan. The network can randomize 6000 subjects with acute SCI and almost unlimited numbers of chronic SCI/year
63 China SCI Network ChinaSCINet has 25 leading spinal cord injury centers in China, Hong Kong, and Taiwan. Network Activities 2004: recruited centers, signed trial agreements. 2005: trained International SCI Classification. 2006: initiated 400-patient observational trial. 2007: initiated phase 1 oral lithium trial at HKU. 2008: phase 2 cord blood transplant trials. 2009: phase 3 cord blood + Lithium trials
64 ChinaSCINet Trials Phase 0 Observational Study (CN100). This trial recruited 600 patients with SCI and collected data for up to a year. Phase 1 Open-label Lithium (CN101). This trial assessed 6-week daily oral lithium treatment of 20 subjects with chronic SCI. Phase 2 Lithium vs Placebo (CN102a). This double-blind trial randomizes 80 subjects with chronic SCI to lithium vs. placebo. Phase 2 Escalating dose cord blood mononuclear cell (CN102b). This trial evaluates safety and efficacy of 1.6, 3.2, 6.4 million HLA-matched CBMC cells transplanted to spinal cords of 40 subjects with chronic SCI, with methylprednisolone & lithium. Phase 3 HLA-matched UCBMC transplants ± Lithium (CN103). This trial will randomize 400 subjects that have received CBMC transplants to lithium or placebo.
66 M ini-lamectomy Dorsal Vertebral Process Spinal cord Lesion Lateral Vertebral Process Spinal Cord
67 Cell Transplantation Cells will be injected into the dorsal root entry zones of the spinal cord above and below the injury site, at a 45 angle and 1 mm deep. The injection volume will be 4, 8, or 16 µliters of 100,000 cells/µliter.
69 CN102B Goals Assess cord blood mononuclear (UCBM) cell dose, i.e. 4, 8, 16 µliter (100,000/µliter) into dorsal root entry zones next to injury. Assess whether methylprednisolone (single bolus 30 mg/kg MP) increases survival of UCBM cell transplants and improves treatment effects. Determine safety and efficacy of lithium after UCBM cell transplants to stimulate proliferation and neurotrophins (NGF, NT3, GDNF, LIF).
70 CN103 Possible Outcomes Neither treatment improve function. We would recommend against cord blood mononuclear cells and lithium treatment of chronic SCI. Both treatment improve neurological function. We will need to do a surgically controlled trial to rule out placebo and surgery-alone effect. Cord blood plus lithium is more effective than cord blood alone. We can strongly recommend the former combination treatment.
71 ChinaSCINet Summary ChinaSCINet is the world s largest spinal cord injury (SCI) clinical trial network. Stemcyte is the best cord blood cell transplant company. Lithium stimulates proliferation and neurotrophin production by umbilical cord blood mononuclear (UCBM) cells. ChinaSCINet will assess safety and optimal dose of HLA-matched UCBM cell transplants for SCI, combined with methylprednisolone and lithium.
72 SCINETUSA Many Americans wanted to go to China for the ChinaSCINet trials. We formed the Spinal Cord Injury Network USA (SCINETUSA). Several U.S. SCI centers have joined NASCINET: Brackenridge Hospital (Austin) UMDNJ/Kessler Institute of Rehabilitation Medicine Thomas Jefferson/McGee Institute of Rehabilitaion Medicine Mt Sinai Medical School (NY) Long Island Jewish Hospital (NY) University of Colorado at Denver Shriner s Hospital (Philadelphia). Wayne State University, Rehabilitation Institute of Michigan
73 Proposed U.S. Trials NA103A. Multicenter phase 3 trial to assess safety and efficacy of umbilical cord blood mononuclear cell (UCBMC) transplants and lithium therapy of chronic SCI in adults (16-60 years old). NA102B. Phase 2 trial to assess feasibility, safety, and efficacy of UCBMC & lithium in older adults (age 60-80). NA102C. Phase 2 trial to assess feasibility, safety and efficacy of UCBMC & lithium in children (age 8-16 years) at Shriner s Hospital in Philadelphia.
74 Stem Cell Policy Wise Young, Ph.D., M.D.
75 U.S. Stem Cell Policy The Bush Administration held back federal funding of all human stem cell research, not just human embryonic stem cell research. The NIH spent <1% of its budget on human stem cell research from 2001 to 2007, too little considering the importance of stem cells. Obama passed executive order to expand federal funding of stem cell research but new draft NIH policy may restrict the research further.
76 Draft NIH Policy Limits embryonic stem cell (ESC) research to cells derived from IVF clinics only and explicitly forbids all cloned or parthenogenetically derived cells. Limits chimera models. New limits on ESC transplants in developing primate and in other animals that may reproduce. New informed consent requirements. ESC must fulfill new informed consent. Most existing ESC lines may not be eligible.
77 California Proposition 71 Funding. Lawsuits have tied up Proposition 71 since 2004 but a favorable decision by the California Supreme Court in 2007 released the funds. The California Institute of Regenerative Medicine (CIRM) has funded training, seed, comprehensive, and facilities grants. The economic recession may limit funding for the coming year but CIRM recently announced a strong commitment to clinical trials.
78 The New Jersey Initiative New Jersey passed the Stem Cell Research Act in 2004, encouraging research on all stem cells, including cloned human embryonic stem cells. In December 2006, the legislature approved a $270 million bond to build the Christopher Reeve Stem Cell Institute in New Brunswick. A $500 million bond for stem cell research was defeated in 2007 and the building of the institute has been suspended.
79 New York State Stem Cells The New York State Legislature, under the leadership of now Governor David Paterson, passed a $500 million bill to fund regenerative medicine in The bill started funding of stem cell research in the state but it is not clear what the budget situation will be in 2009 and The funding of stem cell research will likely be very limited due to the severe budgetary deficits faced by the state.
80 Cell Therapy Industry A thriving cellular therapeutic industry, however, has grown up in the past 8 years in the United States with increasing investments by major companies. Large pharmaceutical companies are investing significantly in stem cell research, including Pfizer, Johnson & Johnson, Bristol-Myers-Squibb, Galaxo-Smith-Kline, Astra-Zeneca, and Roche. Many small companies are now focusing on stem cells, including devices and supply companies.
81 Summary Despite the promise of stem cell therapies, federal funding of the all stem cell research has been very limited, not only of embryonic but adult stem cells. States have started fund stem cell research in California, New Jersey, New York, and other states but the recent recession has cut back on funds. The Obama administration recently issued a draft stem cell policy that further restricts embryonic stem cells and this will hopefully change.
82 For Information: CareCure.org To Donate: Keck.Rutgers.edu JustADollarPlease.org
Stem Cell Quick Guide: Stem Cell Basics What is a Stem Cell? Stem cells are the starting point from which the rest of the body grows. The adult human body is made up of hundreds of millions of different
Stem cells possess 2 main characteristics: -Long-term self renewal. - They give rise to all types of differentiate cells. Sources of pluripotent stem cells: -The inner cell mass of the blastocyst. - Fetal
Stem Cells is the main material for building and regeneration of the body Stem cells are not differentiated and can transform to any cell of organism Stem cells are capable of indefinite renewal through
STEM CELL FACTS The ISSCR is an independent, nonproft organization providing a global forum for stem cell research and regenerative medicine. WHAT ARE STEM CELLS? Stem cells are the foundation cells for
infoaging guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research WHAT ARE STEM CELLS? Stem cells are cells that, in cell cultures
5 Frequently Asked Questions About Adult Stem Cell Research Stem cells are often referred to in the sociopolitical realm with some level of controversy and beyond that, some level of confusion. Many researchers
Module I: The Basic Principles of Stem Cells 1. Basics of Stem Cells a. Understanding the development of embryonic stem cells i. Embryonic stem cells ii. Embryonic germ cells iii. Differentiated stem cell
tem ells /background /information Stem cell research Copyright 2007 MRC Centre for Regenerative Medicine, Institute for Stem Cell Research /02 /information Table of contents Page 01. What are stem cells?
15 Stem Cell Research t a l k it o v e r 1 c l a s s se s s i o n Overview Students read about current scientific research on and the social controversy over embryonic stem cells. On a KWL literacy strategy
Guidance For Research Involving Human Embryonic Stem Cells, Germ Cells, And Cells Obtained From Cord Blood Supreme Council of Health Department of Research Guidance Regarding Research Involving Human Embryonic
Chiang 1 Stem Cell Research: Adult or Somatic Stem Cells Abstract Kelly Chiang Cluster 7 Dr. LeFebvre 07/26/10 Over the past few decades, stem cells have been a controversial topic in the scientific field.
SAMPLE ESSAY C Should Stem Cells Be Used To Treat Human Diseases? Stem cells can be defined as undifferentiated cells that are generated during the development of the embryo. There are two functions ascribed
The Prospect of Stem Cell Therapy in Multiple Sclerosis Multiple sclerosis is a multifocal inflammatory disease of the central nervous system that generally affects young individuals, causing paralysis
STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE What are Stem Cells? Stem cells are the basic building blocks of all the cells, tissues and organs in the human body. The role of the stem
Unit 1 Higher Human Biology Summary Notes a. Cells tissues organs body systems Division of labour occurs in multicellular organisms (rather than each cell carrying out every function) Most cells become
October 2003 Human stem cell research: a novel technology that will benefit patients Information and Position Paper EuropaBio, the European Association for Bio-industries, has 35 corporate members operating
Stem Cell Information The official National Institutes of Health resource for stem cell research Stem Cell Basics Stem cells have the remarkable potential to develop into many different cell types in the
POSITION STATEMENT REGARDING THE USE OF EMBRYONIC AND ADULT HUMAN STEM CELLS IN BIOMEDICAL RESEARCH October 2004 Preamble The American Academy of Neurology (AAN) and the American Neurological Association
CAMBRIDGE UNIVERSITY CENTRE FOR BRAIN REPAIR A layman's account of our scientific objectives What is Brain Damage? Many forms of trauma and disease affect the nervous system to produce permanent neurological
Briefing on the second reading of the Human Fertilisation and Embryology Bill, Monday 19 November 2007. Prepared by the Medical Research Council, Royal Society and Wellcome Trust The Medical Research Council,
2001 Terese Winslow Stem Cells: Scientific Progress and Future Research Directions STEM CELLS: SCIENTIFIC PROGRESS AND FUTURE RESEARCH DIRECTIONS June 2001 This page intentionally left blank TABLE OF CONTENTS
Stem Cells Part 1: What is a Stem Cell? Stem cells differ from other kinds of cells in the body. When a stem cell divides by mitosis, each new cell has the potential to either remain a stem cell or become
An Introduction to Stem Cell Biology Michael L. Shelanski, MD,PhD Professor of Pathology and Cell Biology Columbia University Figures adapted from ISSCR. Presentations of Drs. Martin Pera (Monash University),
Stem Cell Therapy THE DARK AND BRIGHT ASPECTS of Stem Cell Therapy Stem Cells Our last Weapon? The last weapon in the medical armamentarium? Bye the way.. What IS a last weapon? I don t know about today,
It s not something you want to think about, but it s something you want to prepare for. StemCyte cord blood banking offers your family a new lifesaving treatment alternative Why Bank Take the once-in-alifetime
THE PROMISE OF STEM CELL RESEARCH MALIGNANT OSTEOPETROSIS AUTOSOMAL RECESSIVE DENSE SCLEROTIC SKELETON HEMATOLOGIC ABNORMALITIES NEUROLOGIC ABNOMALITIES DEATH IN INFANCY OR EARLY CHILDHOOD SUCCESS RATE
What are Stem Cells? How can they be used in medicine? What is a stem cell????... What is a stem cell????......a cell with the ability to differentiate into specialized cells and renew to become more stem
Human Embryonic Stem Cell Research Frequently Asked Questions and Fact Sheet Stem Cell Science Basics What are stem cells? Stem cells are naturally occurring cells that are not yet fully differentiated.
Background Information 1. What are stem cells? 2. What might stem cell research achieve? 3. Why we need to continue research using embryonic stem cells? 4. Time taken for discoveries 5. Examples of stem
Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with
Stem Stem Cell Cell Engineering-What, Biology and it Application Why, How?? to Biotechnology Srivatsan Kidambi, Ph.D. Assistant Professor Department of Chemical & Biomolecular Engineering University of
Neurotrophic factors and Their receptors Huang Shu-Hong Institute of neurobiology 1 For decades, scientists believed that brain cells of the central nervous system could not regrow following damage due
CHARACTERISTIC FEATURES OF STEM CELLS. CLONING TECHNOLOGIES 1 Science is discovering the unknown Stem cell field is still in its infancy Human embryonic stem cell research is a decade old, adult stem cell
Stem Cells and Hope for Patients by Maureen Condic, Ph.D. Most Americans know someone afflicted with an incurable medical condition. The possibility of stem cell cures has given hope to many who face such
outline What is a stem cell? Tissue stem cell Embryonic stem cell ips cell -production -advantages Applications Issue Conclusion 1 What is a stem cell? Definition: Self-renew themselves a number of times
Knowledge in Motion SCI Education Series Neuroregenerative Properties of Dental Pulp Stem Cells and their Future Potential to Improve Neurological Outcomes in SCI Ricardo Battaglino, PhD Alpdogan Kantarci,
The Therapeutic Potential of Human Umbilical Cord Blood Transplantation for Neonatal Hypoxic-Ischemic Brain Injury and Ischemic Stroke a,b* b,c a a b b b b a b a b c 430 Wang et al. Acta Med. Okayama Vol.
SPRING, 2011 CURRENT STATUS OF STEM CELL TREATMENTS FOR CEREBRAL PALSY: A GUIDE FOR PATIENTS, FAMILIES AND CAREGIVERS *Crystal Ruff, *Jared Wilcox, Michael G. Fehlings Krembil Neuroscience Centre, Toronto
Stem cells and motor neurone disease F Stem cell research has fuelled hope of a treatment for a variety of conditions. This information sheet explains what these cells are and includes details of the current
Chapter 2 The different types of stem cells This chapter investigates the two main types of stem cells, each with their own subcategories: 1. Pluripotent stem cells can become any cell type in the body.
BACKROUNDER: Newborn Stem Cells from Cord Blood and the Brain: Repairing Injury and Improving Function Introduction WITH ONGOING DEVELOPMENTS IN RESEARCH, it is estimated that 1 in every 3 people may benefit
HOUSE OF REPRESENTATIVES TWENTY-FOURTH LEGISLATURE, 2007 STATE OF HAWAII A BILL FOR AN ACT RELATING TO MEDICAL RESEARCH. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: PART I SECTION 1. The legislature
Medical Journal of th e Islamic Republic of Iran Volume 18 Number 3 Fall 1383 November 2004 Basic Science in Medicine ] EXPANSION OF HUMAN CORD BLOOD PRIMITIVE PROGENITORS IN SERUM-FREE MEDIA USING HUMAN
Introducing stem cells 1 Dear speaker This presentation is intended as a flexible tool for scientists, science communicators and educators. Not all the slides will be useful for any one occasion. Choose
Genetics, Ethics &Meaning INItiative (GEMINI) Life Sciences and Society @University of Michigan Module 4 Myths versus Facts The University of Michigan s Stem Cell Research Environment A Case Study MYTH:
Saving Cord Tissue for Your Family Dear Future Mom and/or Dad, All of us at CorCell would like to give you a big CONGRATULATIONS on your pregnancy! Now that you are expecting, you have probably heard about
Stem Cell Basics Last modified on April 08, 2015 About this document This primer on stem cells is intended for anyone who wishes to learn more about the biological properties of stem cells, the important
Cord blood for the treatment of acute lymphoblastic leukemia in young children By Caitlin McGreevy Kiara Paramjothy Pass with Merit RESEARCH PAPER BASED ON PATHOLOGY LECTURES AT MEDLINK 2011 1 Abstract:
Current State of Stem Cell Treatments for Cerebral Palsy: A Guide for Patients, Families and Service Providers Crystal Ruff* Jared Wilcox* Michael G. Fehlings Krembil Neuroscience Centre, Toronto Western
Differentiation = Making specialized cells What is a stem cell? Screws: JM www.logodesignweb.com/stockphoto Differentiation = Making specialized cells What is a stem cell? What the photo shows A lump of
1 ADULT STEM CELLS: THE ONLY ONES THAT REALLY HELP Almost every time we pick up the paper, there is an article on stem cells. It can be very confusing. Here are some simple definitions that can help. Stem
Vertebrate Development Chapter 60 Copyright McGraw-Hill Companies Permission required for reproduction or display Raven - Johnson - Biology: 6th Ed. - All Rights Reserved - McGraw Hill Companies Stages
13-14/11/2006, Istituto Superiore di Sanità Rome, Italy Frontiers in Imaging Science: High Performance Nuclear Medicine Imagers for Vascular Disease Imaging (Brain and Heart) Stem cells for brain cures
Promising Treatments for SCI: What s on The Horizon Shawn Song, MD SCI Fellow University of Washington/VA Puget Sound Healthcare System SCI: A Devastating Injury Epidemiology: Incidence of ~12,000 patients/year.
San Diego Stem Cell Treatment Center Frequently Asked Questions What is a Stem Cell? A stem cell is basically any cell that can replicate and differentiate. This means the cell can not only multiply, but
Therapeutic Potential of Cells Derived from Gestational Tissues: A coming of age Dr Roisin Deane Cell Care Australia Pty Ltd What are Gestational Stem Cells? Stem cells isolated from the gestational tissues
Australian ejournal of Theology 5 (August 2005) Human Embryonic Stem Cells: Ethics, Myths and Realities Jack Martin Abstract: Human embryonic stem (ES) cells can be obtained by the In Vitro Fertilisation
Stem Cell Therapy Applications in pediatric neurology Ali Fatemi, MD Director of Neurogenetics Division Kennedy Krieger Institute Johns Hopkins University Baltimore, USA The Author has nothing to disclose
Dr Paul Turner Research Scientist Dunedin Spinal Cord Society NZ Inc. Who: Aim: Started by Noela & Keith Vallis & people with spinal cord injury (SCI), their families and care-givers in 1988. To support
WMDA Policy Statement on the Utility of Autologous or Family Cord Blood Unit Storage The WMDA Board adopted this policy on 25 th of May 2006. Policy updated _April 2011 The Cord Blood Working Group and
AP BIOLOGY 2012 SCORING GUIDELINES Question 1 Note: At least 1 point must be earned from each of parts (a), (b), (c), and (d) in order to earn a maximum score of 10. The ability to reproduce is a characteristic
Demystifying Stem Cells Brent Bost M.D., CPA, MBA, FACOG Disclaimers Author currently serves on Board of Directors of CordTrack Most applications discussed today are not currently FDA approved and are,
11111 This fact sheet describes the process of cloning and producing stem cells. It outlines the potential benefits, ethical challenges, and provides an overview of the current policies governing the technology.
The Facts about Cord Blood Dear Future Mom and/or Dad, All of us at CorCell would like to give you a big CONGRATULATIONS on your new baby! Now that you are expecting, you have probably heard about saving
Stem cells and motor neurone disease F Stem cell research has fuelled hope of a treatment for a variety of conditions. This information sheet explains what these cells are and how they may be used to create
WMDA Policy Statement for the Utility of Autologous or Family Cord Blood Unit Storage (This policy statement has been approved and adopted by the WMDA board on the 25 th of May 2006) The Cord Blood Registries
CORD BLOOD BANKING FAQ Cord Blood & Stem Cells Q: What is umbilical cord blood (UCB)? A: Bone marrow, peripheral blood and UCB constitute the three primary sources of stem cells. Cord blood, which, until
July 7, 2014 COLUMBIA UNIVERSITY POLICY ON THE CONDUCT OF RESEARCH WITH HUMAN EMBRYOS AND HUMAN EMBRYONIC STEM CELLS* A. INTRODUCTION Columbia University believes that human embryonic and human stem cell
Purification and Expansion of Hematopoietic Stem Cells Based on Proteins Expressed by a Novel Stromal Cell Population Our bodies are constantly killing old, nonfunctional, and unneeded cells and making
Current Issues in Stem Cell Technologies Lance D. Trainor, MD OneBlood, Inc. Objective: The big picture of stem cell therapy Outline: Relevant definitions History of Stem Cell Therapy Hematopoietic Stem
The ethics of stem cell research and treatment Bernard Lo, M.D. March 12, 2009 1 hesc: ethical controversies Moral status of embryo? Clearly a potential person Some believe a person with rights Is hesc
Department of Legislative Services Maryland General Assembly 2006 Session HB 136 FISCAL AND POLICY NOTE House Bill 136 (Delegate Shewell, et al.) Health and Government Operations and Appropriations Public
San Diego Regenerative Medicine Institute Human Stem Cells Key to Regeneration Lineage-Specific Differentiation of Pluripotent Human Embryonic Stem Cells and its Implications for the Future of Cell Therapy
Stem Cell Therapy In Diabetes Mellitus Professor Megahid Abuelmagd Diabetes And Endocrine Unit. Mansoura Faculty Of Medicine For many years, there has been great interest in approaches to the replacement
Introducing stem cells Stem cells in the news Stem cells: Therapeutic Value 16+ year olds February 2010, updated 2012 Objective: Understand the therapeutic value of stem cells About tissue stem cells Stem
[Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017)] Executive Summary Stem Cells have a remarkable ability to develop in various body cells of a human. These occur in the earliest stages
Bioethical and Legal Regulation of the Use of Stem Cells and Stem Cell Technologies in Modern Russia Elena Bryzgalina PhD, Member of the committee on bioethics of the Lomonosov s Moscow State University,
THERAPEUTIC ROLE OF IL-37 IN SPINAL CORD INJURY Rubén López Vales Faculty of Medicine, UAB (Universitat Autònoma de Barcelona) 1. Summary Inflammatory response plays an essential role in protecting the
STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA OVO CLINIC I 8000 BLVD DECARIE, MONTREAL QC H4P 2S4 I 514.798.2000 I OVOCLINIC.COM 2 a therapeutic revolution As the
Stem Cell Background Paper Introduction...2 Stem Cell Basics...3 Stem Cell Process Flow...9 Comparison of Blood, Stem Cells, Tissues and Organs Processes...10 Responsibilities for the Blood, Stem Cells,
Patient Handbook on Stem Cell Therapies Appendix I of the Guidelines for the Clinical Translation of Stem Cells www.isscr.org 2008, International Society for Stem Cell Research 2 Introduction We have all
1. SCOPE AND METHODOLOGY 2. REPORT SYNOPSIS 2.1 General Definitions Myoblasts Pluripotent Cells Multipotent Cells Progenitor Cells Role of Stem Cells in Repairing the Heart Stem Cell Therapy Stem Cells
National Academy of Sciences National Academy of Engineering Institute of Medicine National Research Council IN THIS BOOKLET... WHAT IS A STEM CELL? 3 TYPES OF STEM CELLS 4 WORKING WITH STEM CELLS 9 WHY
Cauley O. Gieb Advanced Health Law HLP Article Umbilical Cord Blood Stem Cell Research: The Proof is in the Cord Today advances in science seem to gain the most recognition and support when the subject
Human Cloning The Science and Ethics of Transplantation Rudolf Jaenisch, M.D. In addition to the moral argument against the use of somatic-cell nuclear for the creation of a child ( reproductive cloning